Cargando…
Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage
BACKGROUND: The biological potential of prostate cancer is extremely variable. Particular interest is focused on markers not expressed in normal prostatic tissues. pS2 protein expression has been demonstrated in a range of malignant tissues in an oestrogen-independent pathway. Recently, it has been...
Autores principales: | Ather, M Hammad, Abbas, Farhat, Faruqui, Nuzhat, Israr, M, Pervez, Shahid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539282/ https://www.ncbi.nlm.nih.gov/pubmed/15588310 http://dx.doi.org/10.1186/1471-2490-4-14 |
Ejemplares similares
-
Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
por: Ather, M Hammad, et al.
Publicado: (2008) -
Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
por: Bilgrami, Shumaila M, et al.
Publicado: (2014) -
Is an excretory urogram mandatory in patients with small to medium-sized renal and ureteric stones treated by extra corporeal shock wave lithotripsy?
por: Ather, M Hammad, et al.
Publicado: (2004) -
Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer
por: Huang, Zhuo, et al.
Publicado: (2023) -
Chromogranin A expression in plasma of critically ill patients
por: Lavaux, T, et al.
Publicado: (2010)